Prenatal Diagnosis of Congenital Heart Diseases and Associations with Serum Biomarkers of Aneuploidy: A Multicenter Prospective Cohort Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We assessed prenatal detection rates of congenital heart disease (CHD) and associations between maternal serum bio markers and non-chromosomal CHD in singleton pregnancies. Materials and Methods: This study was conducted as a secondary analysis of data obtained during a multicenter prospective co hort study that investigated the cost-effectiveness of prenatal testing for fetal aneuploidy. We analyzed the prenatal detection rateand accuracy for CHD screening via ultrasound during the second trimester, as well as associations between serum biomarkersand CHDs, in singleton newborns without chromosomal abnormalities. Results: Among 6715 women, 142 (2.1%) newborns were born with CHDs, of which 67 (1.0%) newborns had major CHDs. Theprenatal detection rate for all CHDs and major CHDs were 34.5% and 58.2%, respectively. After excluding isolated ventricular sep tal defects, the detection rate for critical CHDs was 85.9%. Women with low pregnancy-associated plasma protein A (PAPP-A) (<0.4multiples of the median, MOM) face increased risks of non-chromosomal CHDs [adjusted odds ratio (aOR) 2.76; 95% confidenceinterval (CI) 1.36–5.13] and major CHDs (aOR 7.30; 95% CI 3.18–15.59), compared to those without CHDs. A higher inhibin A level(≥2.5 MOM; aOR 4.84; 95% CI 1.42–12.46) was associated with non-chromosomal major CHDs. Conclusion: Ultrasonography performed during the second trimester by obstetricians detected over 85% of critical CHDs. Low maternal serum PAPP-A or high inhibin-A was associated with non-chromosomal CHDs. These results may contribute to an im provement in prenatal diagnosis of CHDs.
Abstract
Purpose: We assessed prenatal detection rates of congenital heart disease (CHD) and associations between maternal serum bio markers and non-chromosomal CHD in singleton pregnancies. Materials and Methods: This study was conducted as a secondary analysis of data obtained during a multicenter prospective co hort study that investigated the cost-effectiveness of prenatal testing for fetal aneuploidy. We analyzed the prenatal detection rateand accuracy for CHD screening via ultrasound during the second trimester, as well as associations between serum biomarkersand CHDs, in singleton newborns without chromosomal abnormalities. Results: Among 6715 women, 142 (2.1%) newborns were born with CHDs, of which 67 (1.0%) newborns had major CHDs. Theprenatal detection rate for all CHDs and major CHDs were 34.5% and 58.2%, respectively. After excluding isolated ventricular sep tal defects, the detection rate for critical CHDs was 85.9%. Women with low pregnancy-associated plasma protein A (PAPP-A) (<0.4multiples of the median, MOM) face increased risks of non-chromosomal CHDs [adjusted odds ratio (aOR) 2.76; 95% confidenceinterval (CI) 1.36–5.13] and major CHDs (aOR 7.30; 95% CI 3.18–15.59), compared to those without CHDs. A higher inhibin A level(≥2.5 MOM; aOR 4.84; 95% CI 1.42–12.46) was associated with non-chromosomal major CHDs. Conclusion: Ultrasonography performed during the second trimester by obstetricians detected over 85% of critical CHDs. Low maternal serum PAPP-A or high inhibin-A was associated with non-chromosomal CHDs. These results may contribute to an im provement in prenatal diagnosis of CHDs.
참고문헌 (39)
- Ko HS, "A national cohort study evaluating infant and fetal mortality caused by birth defects in Korea", BMJ Open, 7, pp.e017963~ (2017)
- Holland BJ, "Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery : a metaanalysis", Ultrasound Obstet Gynecol, 45, pp.631~638 (2015)
- 고현선, "선천성 질환 태아를 가진 예비부모에 대한 원스톱 통합상담의 의의", Obstetrics & Gynecology Science, 53(08), pp.700~706 (2010), 대한산부인과학회
- Susan Taejung Kim, "The Effect of Multidisciplinary Approach on the Birth Rate of Fetuses with Prenatally Diagnosed Congenital Heart Disease", Journal of Korean Medical Science, 34(24), pp.1~8 (2019), 대한의학회
- Clur SA, "Audit of 10 years of referrals for fetal echocardiography", Prenat Diagn, 31, pp.1134~1140 (2011)
- Carvalho JS, "ISUOG practice guidelines(updated) : sonographic screening examination of the fetal heart", Ultrasound Obstet Gynecol, 41, pp.348~359 (2013)
- Lytzen R, "Mortality and morbidity of major congenital heart disease related to general prenatal screening for malformations", Int J Cardiol, 290, pp.93~99 (2019)
- Snoep MC, "Placenta morphology and biomarkers in pregnancies with congenital heart disease-A systematic review", Placenta, 112, pp.189~196 (2021)
- Binder J, "Evidence for uteroplacental malperfusion in fetuses with major congenital heart defects", PLoS One, 15, pp.e0226741~ (2020)
- Kim SY, "Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing", BMC Pregnancy Childbirth, 18, pp.307~ (2018)
- Courtney JA, "The role of abnormal placentation in congenital heart disease; cause, correlate, or consequence?", Front Physiol, 9, pp.1045~ (2018)
- De Falco M, "Expression and distribution of notch protein members in human placenta throughout pregnancy", Placenta, 28, pp.118~126 (2007)
- Sun IY, "Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane", J Clin Endocrinol Metab, 87, pp.5235~5240 (2002)
- Nicolaides KH, "Screening for fetal aneuploidies at 11 to 13 weeks", Prenat Diagn, 31, pp.7~15 (2011)
- Fantasia I, "Fetal major cardiac defects and placental dysfunction at 11-13 weeks’ gestation", Ultrasound Obstet Gynecol, 51, pp.194~198 (2018)
- Llurba E, "Maternal serum placental growth factor at 11-13 weeks’ gestation and fetal cardiac defects", Ultrasound Obstet Gynecol, 42, pp.169~174 (2013)
- Milunsky A, "Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening", Obstet Gynecol, 55, pp.60~66 (1980)
- Albar H, "Elevated MSAFP levels and congenital heart defects : lack of an association", Am J Med Genet, 49, pp.337~340 (1994)
- Jelliffe-Pawlowski L, "Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects", Prenat Diagn, 31, pp.466~472 (2011)
- Jelliffe-Pawlowski LL, "Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects", Prenat Diagn, 29, pp.570~577 (2009)
- Aitken DA, "Dimeric inhibin A as a marker for Down’s syndrome in early pregnancy", N Engl J Med, 334, pp.1231~1236 (1996)
- Singnoi W, "A cohort study of the association between maternal serum Inhibin-A and adverse pregnancy outcomes : a population-based study", BMC Pregnancy Childbirth, 19, pp.124~ (2019)
- Yue CY, "Are serum levels of inhibin A in second trimester predictors of adverse pregnancy outcome", PLoS One, 15, pp.e0232634~ (2020)
- Rhee S, "Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease", Nat Commun, 9, pp.368~ (2018)
- Perez-Garcia V, "Placentation defects are highly prevalent in embryonic lethal mouse mutants", Nature, 555, pp.463~468 (2018)
- Jones HN, "Hypoplastic left heart syndrome is associated with structural and vascular placental abnormalities and leptin dysregulation", Placenta, 36, pp.1078~1086 (2015)
- Ozcan T, "The association of fetal congenital cardiac defects and placental vascular malperfusion", Pediatr Dev Pathol, 24, pp.187~192 (2021)
- Miremberg H, "The association between severe fetal congenital heart defects and placental vascular malperfusion lesions", Prenat Diagn, 39, pp.962~967 (2019)
- Hoffman JI, "The incidence of congenital heart disease", J Am Coll Cardiol, 39, pp.1890~1900 (2002)
- Marek J, "Prenatal ultrasound screening of congenital heart disease in an unselected national population : a 21-year experience", Heart, 97, pp.124~130 (2011)
- Hornberger LK, "Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study", Circulation, 92, pp.1531~1538 (1995)
- Nadel AS, "Addition of color Doppler to the routine obstetric sonographic survey aids in the detection of pulmonic stenosis", Fetal Diagn Ther, 28, pp.175~179 (2010)
- Zhang Y, "Identification of fetal cardiac anatomy and hemodynamics : a novel enhanced screening protocol", BMC Pregnancy Childbirth, 16, pp.145~ (2016)
- Bronshtein M, "Diverse outcome following early prenatal diagnosis of pulmonary stenosis", Ultrasound Obstet Gynecol, 49, pp.213~218 (2017)
- Yagel S, "Congenital heart defects : natural course and in utero development", Circulation, 96, pp.550~555 (1997)
- Freud LR, "Low rate of prenatal diagnosis among neonates with critical aortic stenosis : insight into the natural history in utero", Ultrasound Obstet Gynecol, 45, pp.326~332 (2015)
- Satomi G, "Guidelines for fetal echocardiography", Pediatr Int, 57, pp.1~21 (2015)
- Andescavage N, "3-D volumetric MRI evaluation of the placenta in fetuses with complex congenital heart disease", Placenta, 36, pp.1024~1030 (2015)
- Leon RL, "Neuroplacentology in congenital heart disease : placental connections to neurodevelopmental outcomes", Pediatr Res, 91, pp.787~794 (2022)